Get started
Author

Anna Maria Scattolin

Observed names: A M Scattolin, A. M. Scattolin, A. Scattolin, A.M. Scattolin, Anna M Scattolin, Anna M. Scattolin, Annamaria Scattolin, Scattolin Am, Scattolin, AM, Scattolin, Anna Maria
Observed institution: Ospedale dell' Angelo
OpenAlex ID: A5008839925
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
2020 · Francesco Passamonti, Chiara Cattaneo, et al. · The Lancet Haematology · 552
PDF
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
2009 · Renato Bassan, Orietta Spinelli, et al. · Blood · 428
PDF
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy
2014 · C Girmenia, G M Rossolini, et al. · Bone Marrow Transplantation · 189
PDF
Burkitt lymphoma in adolescents and young adults: management challenges
2016 · Massimo Dozzo, Francesca Carobolante, et al. · Adolescent Health Medicine and Therapeutics · 88
PDF
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
2016 · Federico Lussana, Tamara Intermesoli, et al. · Transplantation and Cellular Therapy · 88
PDF
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia
2014 · R Bassan, O Spinelli, et al. · Blood Cancer Journal · 66
PDF
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
2020 · Fabio Guolo, Luana Fianchi, et al. · Blood Cancer Journal · 59
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2021 · Carlo Visco, Luigi Marcheselli, et al. · Blood Advances · 55
PDF
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program
2013 · T. Intermesoli, A. Rambaldi, et al. · Haematologica · 50
PDF
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
2020 · Renato Bassan, Chiara Pavoni, et al. · Blood Cancer Journal · 46
PDF
Current and future management of Ph/BCR-ABL positive ALL
2014 · Elena Maino, Rosaria Sancetta, et al. · Expert Review of Anticancer Therapy · 46
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
2023 · Renato Bassan, Sabina Chiaretti, et al. · Blood Advances · 37
PDF
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
2019 · Renato Bassan, Tamara Intermesoli, et al. · Blood Advances · 32
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia
2015 · R. Bassan, A. Masciulli, et al. · Haematologica · 32
PDF
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
2011 · F. Mannelli, G. Gianfaldoni, et al. · Haematologica · 30
PDF
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
2020 · Chiara Caprioli, Federico Lussana, et al. · Haematologica · 23
PDF
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia
2017 · Renato Bassan, Tamara Intermesoli, et al. · Clinical Lymphoma Myeloma & Leukemia · 22
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)
2016 · Renato Bassan, Arianna Masciulli, et al. · Blood · 22
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study
2022 · Michelina Dargenio, Massimiliano Bonifacio, et al. · British Journal of Haematology · 21
PDF
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort
2022 · Michele Merli, Isacco Ferrarini, et al. · Hematological Oncology · 15
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial
2020 · Giacomo Gianfaldoni, Francesco Mannelli, et al. · Blood Advances · 15
PDF
Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-negative Adult Acute Lymphoblastic Leukemia
2014 · Orietta Spinelli, Manuela Tosi, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 13
PDF
Real World Study on the Best CPX ‐351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation
2025 · Fabio Guolo, Luana Fianchi, et al. · American Journal of Hematology · 11
PDF
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
2020 · Silvia Salmoiraghi, Roberta Cavagna, et al. · Cancers · 11
PDF
Immunotherapy approaches to treat adult acute lymphoblastic leukemia
2016 · Elena Maino, Massimiliano Bonifacio, et al. · Expert Review of Hematology · 10
Works count: 55
Citation count: 2,023
H-index: 19
I10-index: 25
Year
Topic
Type